[go: up one dir, main page]

KR910015302A - 생체내 활성을 갖는 폴리펩티드를 지속적으로 방출시키는 조성물 - Google Patents

생체내 활성을 갖는 폴리펩티드를 지속적으로 방출시키는 조성물 Download PDF

Info

Publication number
KR910015302A
KR910015302A KR1019900001689A KR900001689A KR910015302A KR 910015302 A KR910015302 A KR 910015302A KR 1019900001689 A KR1019900001689 A KR 1019900001689A KR 900001689 A KR900001689 A KR 900001689A KR 910015302 A KR910015302 A KR 910015302A
Authority
KR
South Korea
Prior art keywords
composition
growth hormone
polypeptide
vivo activity
tocopherol
Prior art date
Application number
KR1019900001689A
Other languages
English (en)
Other versions
KR920005688B1 (ko
Inventor
김남중
이병건
Original Assignee
최근선
주식회사 럭키
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 최근선, 주식회사 럭키 filed Critical 최근선
Priority to KR1019900001689A priority Critical patent/KR920005688B1/ko
Priority to AU70937/91A priority patent/AU653325B2/en
Priority to NZ237084A priority patent/NZ237084A/en
Priority to JP3041336A priority patent/JP2620417B2/ja
Publication of KR910015302A publication Critical patent/KR910015302A/ko
Application granted granted Critical
Publication of KR920005688B1 publication Critical patent/KR920005688B1/ko
Priority to US08/275,329 priority patent/US5520927A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

내용 없음

Description

생체내 활성을 갖는 폴리펩티드를 지속적으로 방출시키는 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제 1도는 표 1에 따른 그래프, 제 2도는 표 2에 따른 그래프.

Claims (7)

  1. 초산토코페롤 또는 토코페롤 및 그의 유도체로 구성된 군에서 선택된 1종 또는 2종이상의 물질과 지연 보조제로 이루어진 것을 특징으로 하는 생체내 활성을 갖는 폴리펩티드를 지속적으로 방출시키는 조성물.
  2. 제1항에 있어서, 상기 지연보조제는 알루미늄 모노스테아레이트, 칼슘 스테아레이트, 밀랍, 카르나우바왁스 또는 파라핀인 것을 특징으로 하는 생체내 활성을 갖는 폴리펩티드를 지속적으로 방출시키는 조성물.
  3. 제1항에 있어서, 상기 초산토코페롤 또는 토코페롤 및 그 유도체는 조성물 전체중량에 대하여 95 내지 98중량%사용되는 것을 특징으로 하는 생체내 활성을 갖는 폴리펩티드를 지속적으로 방출시키는 조성물.
  4. 제1항 또는 제2항에 있어서, 상기 지연보조제는 조성물 전체중량에 대하여 2 내지 5중량%사용되는 것을 특징으로 하는 생체내 활성을 갖는 폴리펩티드를 지속적으로 방출시키는 조성물.
  5. 제1항에 있어서, 상기 폴리펩티드는 동물 성장호르몬, 인간 성장호르몬 및 인슐린, 인터페론, 인터루킨-Ⅱ, 종양괴사인자, 콜로니자극인자 및 그 유사체로 이루어진 군에서 선택된 1종의 폴리펩티드인 것을 특징으로 하는 생체내 활성을 갖는폴리펩티드를 지속적으로 방출시키는 조성물.
  6. 제5항에 있어서, 상기 동물 성장호르몬은 착이온 금속을 부착시키지 않은 것이거나 또는 착이온 금속을 부착시킨 것을 특징으로 하는 생체내 활성을 갖는 폴리펩티드를 지속적으로 방출시키는 조성물.
  7. 제5항 또는 제6항에 있어서, 상기 동물 성장호르몬은 우형소마토트로핀, 돼지 성장호르몬, 산양 및 면양 성장호르몬, 가금 성장호르몬, 연어 성장호르몬 또는 어패류 성장호르몬인 것을 특징으로 하는 생체내 활성을 갖는 폴리펩티드를 지속적으로 방출시키는 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900001689A 1990-02-12 1990-02-12 생체내 활성을 갖는 폴리펩티드를 지속적으로 방출시키는 조성물 KR920005688B1 (ko)

Priority Applications (5)

Application Number Priority Date Filing Date Title
KR1019900001689A KR920005688B1 (ko) 1990-02-12 1990-02-12 생체내 활성을 갖는 폴리펩티드를 지속적으로 방출시키는 조성물
AU70937/91A AU653325B2 (en) 1990-02-12 1991-02-11 A composition durably releasing bioactive polypeptides
NZ237084A NZ237084A (en) 1990-02-12 1991-02-11 Composition for the prolonged release of somatotropin comprising the somatotropin, a tocopherol component, and an assistant delaying agent
JP3041336A JP2620417B2 (ja) 1990-02-12 1991-02-12 生物学的活性を有するポリペプチドを持続的に放出する組成物
US08/275,329 US5520927A (en) 1990-02-12 1994-07-14 Method for the preparation of sustained release somatotropin and product produced thereby

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019900001689A KR920005688B1 (ko) 1990-02-12 1990-02-12 생체내 활성을 갖는 폴리펩티드를 지속적으로 방출시키는 조성물

Publications (2)

Publication Number Publication Date
KR910015302A true KR910015302A (ko) 1991-09-30
KR920005688B1 KR920005688B1 (ko) 1992-07-13

Family

ID=19296007

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900001689A KR920005688B1 (ko) 1990-02-12 1990-02-12 생체내 활성을 갖는 폴리펩티드를 지속적으로 방출시키는 조성물

Country Status (1)

Country Link
KR (1) KR920005688B1 (ko)

Also Published As

Publication number Publication date
KR920005688B1 (ko) 1992-07-13

Similar Documents

Publication Publication Date Title
Vesely Biotin enhances guanylate cyclase activity
BG93923A (bg) Метод за получаване на състав за контролирано освобождаване на активното вещество
ATE230259T1 (de) Verwendung von redispergierbaren polymerpulvern oder polymergranulaten als bindemittel zur herstellung von festen pharmazeutischen darreichungsformen
FI820467L (fi) Farmaceutiska kompositioner som frigoers kontinuerligt
NZ227787A (en) Peptides and compositions having growth hormone regulatory effects
CA2086247A1 (en) Food and Pharmaceutical Compositions Containing Short Chain Monounsaturated Fatty Acids and Methods of Using
MX173196B (es) Metodo para producir un implanto de liberacion controlada y el producto obtenido con el mismo
ATE272321T1 (de) Modifizierte fettmischungen
Amici et al. Induction of thermotolerance by prostaglandin A in human cells
NO941681L (no) Humane IL-4 mutant proteiner
Kukita et al. Heat-treated osteoblastic cell (ROS17/2.8)-conditioned medium induces the formation of osteoclast-like cells
NO933345D0 (no) Forbedrede retardsystemer for tidsforsinket frisetting avmedisinske og/eller biologiske aktive bestanddeler fra etdepot-baerermateriale
Thornton et al. Epidermal growth factor in the healing of second degree burns: a controlled animal study
KR910015302A (ko) 생체내 활성을 갖는 폴리펩티드를 지속적으로 방출시키는 조성물
GB8603964D0 (en) Compositions
Williamson Protein metabolism during healing of wounds
Kasai et al. Presence of high affinity receptor for interleukin-1 (IL-1) on cultured porcine thyroid cells
ATE238063T1 (de) Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon- freisetzungsfaktor
GB8924968D0 (en) Compositions of some therapeutic advantage from fish and other aquatic animals combined with garlic including or excluding the garlic actice principle allicin
UA27055C2 (uk) Лікарський препарат імуhозаміhhої дії hа осhові клітиhhої суспеhзії та спосіб лікуваhhя сиhдрому hабутого імуhодефіциту (віл-іhфекції) з використаhhям цього препарату
DK0741579T3 (da) Vandig formulering med forhalet frigivelse
NIKIFOROVA Characteristics of tissue culture growth of the mammary glands of mice from a non-cancer line (D) after the addition of androsterone and 17-beta-estradiol to the culture medium
Billiau The interferons: a brief introduction
Fleck Protein metabolism after injury
Brown et al. Connective tissue metabolism in swine. 1. Age related changes in levels of total and soluble hydroxyproline, elastin, hexosamine and non-collagen protein levels in the uterus and aorta during growth

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19900212

PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19900212

Comment text: Request for Examination of Application

PG1501 Laying open of application
G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19920612

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19920930

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19921217

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19921217

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19950630

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19960627

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19970624

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 19980623

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 19990701

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20000628

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20010629

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20020628

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20030701

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20040624

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20050621

Start annual number: 14

End annual number: 14

PR1001 Payment of annual fee

Payment date: 20060616

Start annual number: 15

End annual number: 15

PR1001 Payment of annual fee

Payment date: 20070626

Start annual number: 16

End annual number: 16

PR1001 Payment of annual fee

Payment date: 20080624

Start annual number: 17

End annual number: 17

FPAY Annual fee payment

Payment date: 20090612

Year of fee payment: 18

PR1001 Payment of annual fee

Payment date: 20090612

Start annual number: 18

End annual number: 18

EXPY Expiration of term
PC1801 Expiration of term